Study of Platelet Rich Plasma Injection for Treating Various Musculoskeletal Conditions Including Osteoarthritis and Tendinopathy

What this Trial Is About

Researchers are evaluating the use of Platelet-Rich Plasma PRP injections for treating various musculoskeletal MSK conditions, including osteoarthritis OA in multiple joints, tendinopathies, and plantar fasciitis. The study aims to track changes in pain, function, and patient satisfaction over a one-year period after receiving PRP, helping to build a detailed registry of treated patients. PRP has gained attention as a treatment with potential benefits and lower risks compared to corticosteroids, which are commonly used for these conditions. Participants who qualify and agree to join will receive a PRP injection prepared from their own blood. This involves drawing blood, spinning it in a centrifuge to concentrate platelets in the plasma, and then injecting this platelet-rich plasma into the affected area. The process keeps the blood sealed from air and uses specialized equipment for preparation. Follow-up surveys will be completed at multiple points 2 weeks, 6 weeks, 3 months, 6 months, and 12 months after the injection. During the study, participants will undergo blood analysis to evaluate the PRP composition and complete various assessments measuring pain, function, and satisfaction. Outcome measures include the Visual Analog Score for pain, global satisfaction, and condition-specific tools such as the Western Ontario and McMaster Universities Arthritis Index for knees and other joint outcome questionnaires. The study will monitor these measures over 12 months, with a primary focus on pain at 6 months, to assess the effects of PRP treatment on MSK conditions.

Platelet Rich Plasma for Musculoskeletal Conditions